A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 2, Pages 411
Publisher
MDPI AG
Online
2020-02-12
DOI
10.3390/cancers12020411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The metalloprotease ADAM17 in inflammation and cancer
- (2019) Stefan Düsterhöft et al. PATHOLOGY RESEARCH AND PRACTICE
- CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor
- (2019) Bin Liu et al. Cancers
- ADAM17: An Emerging Therapeutic Target for Lung Cancer
- (2019) Saad et al. Cancers
- The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms
- (2018) Taishu Wang et al. Cell Communication and Signaling
- Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
- (2017) Marcia L. Moss et al. MEDIATORS OF INFLAMMATION
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer
- (2016) A. Sharma et al. CLINICAL CANCER RESEARCH
- Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
- (2016) Eitan Wong et al. Scientific Reports
- Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
- (2015) Andreas Plückthun Annual Review of Pharmacology and Toxicology
- Targeting the Sheddase Activity of ADAM17 by an Anti-ADAM17 Antibody D1(A12) Inhibits Head and Neck Squamous Cell Carcinoma Cell Proliferation and Motility via Blockage of Bradykinin Induced HERs Transactivation
- (2014) Yanchao Huang et al. International Journal of Biological Sciences
- The efficacy of cetuximab in a tissue-engineered three-dimensional in vitro model of colorectal cancer
- (2014) Tarig Magdeldin et al. Journal of Tissue Engineering
- Hyperactivation of constitutively dimerized oncogenic EGF receptors by autocrine loops
- (2012) J A G C Laisney et al. ONCOGENE
- Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor Recycling
- (2011) Ykelien L. Boersma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DARPins Recognizing the Tumor-Associated Antigen EpCAM Selected by Phage and Ribosome Display and Engineered for Multivalency
- (2011) Nikolas Stefan et al. JOURNAL OF MOLECULAR BIOLOGY
- Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
- (2010) J. N. Kyula et al. CLINICAL CANCER RESEARCH
- Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
- (2008) Daniel Steiner et al. JOURNAL OF MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started